07/26/2012 - 9:21am

The Senate Committee on Commerce, Science and Transportation on Wednesday released a staff report on the investigation into the gray market for pharmaceuticals — what the committee defined as "shady operators who make enormous profits by buying hard-to-find drugs and reselling them at huge markups" — specifically naming pharmacies as a primary culprit.

07/26/2012 - 7:30am

Qualitest Pharmaceuticals announced that it has received approval from the Food and Drug Administration for its generic version of an epilepsy treatment.

07/25/2012 - 8:58am

Sagent Pharmaceuticals has launched a generic antibiotic, the company said.

07/24/2012 - 3:14pm

A district court ruled in favor of Pfizer and Northwestern University in a patent infringement case relating to Lyrica (pregabalin).

07/23/2012 - 2:50pm

Blu Pharmaceuticals has named Joe Dombrowski to the newly created position of VP corporate development, the company said.

07/23/2012 - 11:27am

The Centers for Medicare and Medicaid Services on Monday hosted a public meeting to entertain a controversial payment adjustment — called "inherent reasonableness" — in reimbursing for non-mail-order diabetes supplies.

07/20/2012 - 10:41am

The Council for Responsible Nutrition announced it is hosting a free webinar on the interaction between dietary supplements and pharmaceutical drugs via the professional networking website Pharmacist Society, an online community created by Skipta and sponsored by The Drug Store News Group, and Generation NP, a website that serves nurse practitioners.

07/19/2012 - 10:31am

Israeli drug maker Taro Pharmaceutical Industries has rejected India-based Sun Pharmaceutical Industries' takeover bid, Taro said Thursday.

07/18/2012 - 11:43am

Teva Pharmaceuticals has introduced a generic drug for treating attention deficit hyperactivity disorder, the company said.